TRPC3 and ovarian benign neoplasm: We validated that TRPC3 mRNA were dramatically upregulated in ovarian cancer tissues compared with benign ovarian tumor tissues (Fig. 4A), and were higher in late stages of ovarian cancer tissues compared with the early stages (Fig. 4B).